Results 51 to 60 of about 216,096 (151)
Radiology Case ReportsMultiple system atrophy is a rare and quickly progressing neurological condition characterized by autonomic failure, parkinsonism, or cerebellar ataxia.
Nor Osman Sidow, MD +4 more
doaj +1 more source
International Referral and Elderly Care—A Case of Atypical Parkinsonism and Cerebellar Atrophy
International Journal of Gerontology, 2009 A 66-year-old male patient had a history of hepatitis B, was a hepatitis C carrier, and had hypertension. He was referred to our family medicine international clinic by the Canadian Physician's Referral Service.
Ying-Hua Shieh +2 more
doaj +1 more source
FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy. [PDF]
PLoS ONE, 2013 Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically characterized by accumulation of the protein p25α in cell bodies of oligodendrocytes followed by accumulation of aggregated α-synuclein in so-called glial ...
Christine L Kragh +12 more
doaj +1 more source
Models of Multiple System Atrophy [PDF]
, 2013 Multiple system atrophy (MSA) is a predominantly sporadic, adult-onset, fatal neurodegenerative disease of unknown etiology. MSA is characterized by autonomic failure, levodopa-unresponsive parkinsonism, cerebellar ataxia and pyramidal signs in any combination. MSA belongs to a group of neurodegenerative disorders termed α-synucleinopathies, which also
Lisa, Fellner +2 more
openaire +2 more sources
Multiple system atrophy and cognitive dysfunction
Chinese Journal of Contemporary Neurology and Neurosurgery, 2016 As the survival of patients with multiple system atrophy (MSA) is prolonged, patients may present cognitive dysfunction or even dementia in addition to autonomic dysfunction, damage of extrapyramidal system and cerebellar ataxia.
Sen-yang LANG
doaj
MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
Frontiers in Neuroscience, 2019 Multiple system atrophy (MSA) is an adult onset, fatal disease, characterized by an accumulation of alpha-synuclein (α-syn) in oligodendroglial cells.
Chunchen Xiang +3 more
doaj +1 more source
Treatment of multiple system atrophy using intravenous immunoglobulin
BMC Neurology, 2012 Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia. Disease-modifying therapies are unavailable.
Novak Peter +5 more
doaj +1 more source
Research advances on multiple system atrophy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2011 DOI：10.3969/j.issn.1672-6731.2011.01 ...
Xianwen CHEN
doaj
Diagnosis and therapy of multiple system atrophy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2012 Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder characterised clinically by any combination of autonomic, cerebellar ataxia, parkinsonian, and pyramidal signs.
Wei⁃hong GU
doaj
Pregnancy in multiple system atrophy: a case report
Journal of Medical Case Reports, 2011 Introduction Multiple system atrophy is a late, adult-onset α-synucleinopathy with no data on the effect of pregnancy on the disease course. Early stage multiple system atrophy can be difficult to distinguish from Parkinson's disease.
Zhu Lirong +3 more
doaj +1 more source